Communication about the ending of anticancer treatment and transition to palliative care

Annals of Oncology : Official Journal of the European Society for Medical Oncology
T MoritaY Uchitomi

Abstract

Communication about the ending of anticancer treatment and transition to palliative care is a difficult task for oncologists. The primary aims of this study were to clarify family-reported degree of emotional distress and the necessity for improvement in communication methods when communicating about the ending of anticancer treatment, and to identify factors contributing to the levels of emotional distress and the necessity for improvement. A multi-center questionnaire survey was conducted on 630 bereaved family members of cancer patents who received specialized palliative care in Japan. A total of 318 responses were analyzed (effective response rate, 62%). Thirty-nine percent of the bereaved family members reported that they were 'very distressed' in receiving information about the ending of anticancer treatment, and 19% reported 'considerable' or 'much' improvement was necessary in the communication methods. High-level emotional distress was significantly associated with younger patient age, female family gender, the experience of the physician stating she/he could do nothing for the patient, the physician's unwillingness to explore their feelings, and prognostic disclosure of definite survival periods without probabilities ...Continue Reading

Citations

Feb 24, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mitsunori MiyashitaYosuke Uchitomi
Feb 23, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bejoy C ThomasManoj Pandey
Feb 23, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kazuki SatoYasuo Shima
May 26, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mieko FukuiPeter L Hudson
Mar 1, 2011·Palliative & Supportive Care·Louise OlssonMaria Friedrichsen
Nov 3, 2005·Nature Clinical Practice. Oncology·Anthony L Back
Sep 7, 2007·Journal of Palliative Medicine·Joshua S BarclayJames A Tulsky
Mar 6, 2010·Journal of Palliative Medicine·Eytan SzmuilowiczSusan Block
Mar 13, 2013·Journal of Palliative Medicine·Hiroyuki OtaniKazuyoshi Sasaki
Sep 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Braga
Feb 5, 2009·Japanese Journal of Clinical Oncology·Maiko Fujimori, Yosuke Uchitomi
Jul 19, 2011·Japanese Journal of Clinical Oncology·Hiroyuki OtaniKeiko Shiraisi
Feb 14, 2006·Current Opinion in Pediatrics·Jennifer W Mack, Joanne Wolfe
Apr 6, 2012·Current Opinion in Oncology·Jan GaertnerR Voltz
Aug 15, 2013·Journal of Oncology Practice·Leeat GranekPaolo Mazzotta
Jul 28, 2011·Cancer Management and Research·Bethany J Russell, Alicia M Ward
Jan 17, 2008·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Akiko AkiyamaHiroshi Mikami
Jun 3, 2011·Indian Journal of Palliative Care·Jaspreet Kaur, Bidhu K Mohanti
Sep 27, 2012·The Permanente Journal·Karen TallmanLaurel Pantel
Dec 7, 2013·Japanese Journal of Clinical Oncology·Yoko NakazawaMitsunori Miyashita
Sep 21, 2013·Indian Journal of Palliative Care·Sv Suryanarayana Deo, T Thejus
Jun 16, 2010·Journal of Gastroenterology·Yoshiyuki YamagishiToshifumi Hibi
Dec 15, 2010·Journal of Pain and Symptom Management·Saran YoshidaYasuo Shima
Jun 29, 2010·Journal of Affective Disorders·Daisuke FujisawaYoshiharu Kim
Oct 14, 2009·Journal of Pain and Symptom Management·Tomoyo SasaharaSeiji Bito
Mar 27, 2009·Journal of Pain and Symptom Management·Mitsunori MiyashitaYosuke Uchitomi
Jul 31, 2007·Journal of Pain and Symptom Management·Tatsuya MoritaYosuke Uchitomi
Sep 19, 2008·Cancer·Anthony L BackRobert M Arnold
Dec 1, 2007·Journal of the American Geriatrics Society·Quyen Ngo-MetzgerEllen P McCarthy
Nov 10, 2007·Psycho-oncology·Mitsunori MiyashitaYosuke Uchitomi
May 24, 2012·Psycho-oncology·Hsien-Liang HuangWen-Yu Hu
Oct 6, 2010·Journal of Clinical Nursing·Kelli I StajduharCharmaine Kim-Sing
Apr 8, 2016·The Journal of the Association of Nurses in AIDS Care : JANAC·Jacquelyn SlomkaBarbara J Daly
Dec 2, 2009·Journal of Pain & Palliative Care Pharmacotherapy·Joseph LowyDonna Zhukovsky
Dec 24, 2014·Social Science & Medicine·Courtney Davis
Dec 12, 2012·Social Science & Medicine·Alex BroomJon Adams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.